Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation

No standard exists for the treatment of myelodysplastic syndrome relapsing after allogeneic stem cell transplantation. We performed a retrospective registry analysis of outcomes and risk factors in 698 patients, treated with different strategies. The median overall survival from relapse was 4.7 mont...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Haematologica
المؤلفون الرئيسيون: Schmid, Christoph, de Wreede, Liesbeth C., van Biezen, Anja, Finke, Jürgen, Ehninger, Gerhard, Ganser, Arnold, Volin, Liisa, Niederwieser, Dietger, Beelen, Dietrich, Alessandrino, Paolo, Kanz, Lothar, Schleuning, Michael, Passweg, Jakob, Veelken, Hendrik, Maertens, Johan, Cornelissen, Jan J., Blaise, Didier, Gramatzki, Martin, Milpied, Noel, Yakoub-Agha, Ibrahim, Mufti, Ghulam, Rovira, Montserrat, Arnold, Renate, de Witte, Theo, Robin, Marie, Kröger, Nikolaus
التنسيق: Artigo
اللغة:Inglês
منشور في: Ferrata Storti Foundation 2018
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5792268/
https://ncbi.nlm.nih.gov/pubmed/29101205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.168716
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة